Clinical Milestone Payment
Longevity & Biotech Royalties
Definition
A clinical milestone payment is a contingent payment triggered by specified drug development, regulatory, commercial, or licensing events.
Why it matters
Milestones can create asymmetric upside, but timing and payment depend on trial success, regulatory decisions, contract interpretation, and counterparty behavior.
Common misconceptions
- •A listed milestone is not the same as expected cash flow; the trigger may never occur.
- •Milestone economics can be binary even when attached to a diversified royalty portfolio.
Technical details
Trigger Types
Milestones may be tied to trial enrollment, phase completion, positive endpoints, regulatory filing, approval, first commercial sale, sales thresholds, or sublicensing.
Diligence
Review trial design, endpoint risk, sponsor incentives, contractual discretion, notice requirements, dispute mechanisms, and payment timing after trigger satisfaction.